Therapy News and Research

RSS

New study indicates a way to improve cancer immunotherapy

Cancer immunotherapy drugs trigger the body's immune system to attack tumors and have revolutionized the treatment of certain cancers, such as lymphoma, lung cancer and melanoma. Yet, while some patients respond well to the drugs, others don't respond at all. Cancer immunologists want to change that.

23 Oct 2019

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

Lung cancer is the second most common type of cancer and leading cause of cancer death in men and women, with non-small cell lung cancer (NSCLC) accounting for up to 90% of cases. Somatic mutations heavily impact the sensitivity of NSCLC patients to various drug treatments, and are critical for choosing the most effective targeted therapies for this cancer.

23 Oct 2019

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

The National Institutes of Health plans to invest at least $100 million over the next four years toward an audacious goal: develop affordable, gene-based cures for sickle cell disease and HIV.

23 Oct 2019

Hong Kong Baptist University receives FDA orphan drug designation for novel aptamer

A research team from the School of Chinese Medicine at Hong Kong Baptist University has successfully developed a novel aptamer, i.e. a single-stranded piece of DNA, for the treatment of osteogenesis imperfecta (OI) with the aid of artificial intelligence (AI) technology.

23 Oct 2019

Therapy for common vision disorder fails to improve children's reading test scores

Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.

23 Oct 2019

Novel noninvasive imaging technique can provide information about thyroid disorders

A combination of multispectral optoacoustic tomography (MSOT) and ultrasound has been used to noninvasively characterize a range of thyroid disorders, according to new research published in the October issue of The Journal of Nuclear Medicine.

23 Oct 2019

Lifestyle of bacteria determines how they evolve antibiotic resistance

How bacteria live -- whether as independent cells or in a communal biofilm -- determines how they evolve antibiotic resistance, which could lead to more personalized approaches to antimicrobial therapy and infection control.

23 Oct 2019

Celiac disease may now be curable with biodegradable nanoparticles

A phase 2 trial just concluded shows that people with celiac disease may now be able to hope for a cure, through a treatment that makes the immune system tolerant towards gluten. This could eventually make it possible for such individuals to eat gluten-containing foods without fear.

22 Oct 2019

ASTRO and ACR release updated practice parameters for radiation therapy

The American Society for Radiation Oncology and the American College of Radiology recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer.

22 Oct 2019

Hope for stressed-out parents of extremely picky eaters

A new study published in the journal Cognitive and Behavioral Practice brings hope to parents who are at their wits’ end over their children’s refusal to eat one or more food groups.

22 Oct 2019

New technology allows delivery of drugs directly to cancer cells

A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.

22 Oct 2019

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.

22 Oct 2019

LSU Health New Orleans awarded $1.74 million to advance research on Usher syndrome

Jennifer J. Lentz, PhD, Associate Professor at LSU Health New Orleans Neuroscience Center of Excellence and Departments of Otorhinolaryngology, Genetics and Ophthalmology, in collaboration with Robert K. Koenekoop MD, PhD and Professor of Pediatric Surgery, Human Genetics and Ophthalmology at McGill University in Montreal, Quebec, Canada, has been awarded a $1.74 million USD grant to advance research on Usher syndrome.

22 Oct 2019

Research introduces a revolutionary treatment for infections

Titanium has many properties that make it a great choice for use in implants. Its low density, high stiffness, high biomechnanical strength-to-weight ratio, and corrosion resistance have led to its use in several types of implants, from dental to joints.

22 Oct 2019

Support coaches for smoother transitions to home care and postoperative recovery

With healthcare being an ever-changing landscape, bundled payments are becoming a more popular option for hospitals since it allows physicians to allocate a set amount of money to cover a patient's stay from their hospital admission all the way up to 90 days after their procedure.

22 Oct 2019

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.

22 Oct 2019

New treatment shows promise to reverse celiac disease

Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.

22 Oct 2019

Cold plasma jets as promising tool for minimally invasive cancer therapy

Modern advances in oncology have significantly improved cancer survival rates. However, personalized treatment methods are necessary, since tumors may behave differently for different patients.

21 Oct 2019

One in three patients may experience side effects from ketamine infusions for pain management

As the opioid epidemic continues to devastate the United States, ketamine use has grown as a pain management alternative, yet more than one in three patients may experience side effects such as hallucinations and visual disturbances, suggests new research presented at the ANESTHESIOLOGY 2019 annual meeting.

21 Oct 2019

CHOP offers help and cure for children with overly picky eating habits

Families dealing with the stress and frustration of their child's overly picky eating habits may have a new addition to their parental toolbox.

21 Oct 2019

Therapy News and Research

New study indicates a way to improve cancer immunotherapy

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

Hong Kong Baptist University receives FDA orphan drug designation for novel aptamer

Therapy for common vision disorder fails to improve children's reading test scores

Novel noninvasive imaging technique can provide information about thyroid disorders

Lifestyle of bacteria determines how they evolve antibiotic resistance

Celiac disease may now be curable with biodegradable nanoparticles

ASTRO and ACR release updated practice parameters for radiation therapy

Hope for stressed-out parents of extremely picky eaters

New technology allows delivery of drugs directly to cancer cells

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

LSU Health New Orleans awarded $1.74 million to advance research on Usher syndrome

Research introduces a revolutionary treatment for infections

Support coaches for smoother transitions to home care and postoperative recovery

Oncolytics Biotech and PrECOG collaborate to study metastatic breast cancer

New treatment shows promise to reverse celiac disease

Cold plasma jets as promising tool for minimally invasive cancer therapy

One in three patients may experience side effects from ketamine infusions for pain management

CHOP offers help and cure for children with overly picky eating habits

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News